- Home
- WALD vs XGN Comparison
WALD vs XGN Comparison
Compare WALD & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WALD | XGN |
|---|---|---|
| Founded | 1988 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.8M | 253.9M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WALD | XGN |
|---|---|---|
| Price | $1.89 | $6.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $4.76 | ★ $13.67 |
| AVG Volume (30 Days) | 183.3K | ★ 307.0K |
| Earning Date | 11-24-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $274,560,000.00 | $63,599,000.00 |
| Revenue This Year | $4.61 | $22.15 |
| Revenue Next Year | $11.22 | $15.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.22 | 14.08 |
| 52 Week Low | $1.48 | $2.67 |
| 52 Week High | $4.18 | $12.23 |
Technical Indicators
Market Signals| Indicator | WALD | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 38.94 | 27.86 |
| Support Level | $2.18 | $7.01 |
| Resistance Level | $2.25 | $7.29 |
| Average True Range (ATR) | 0.21 | 0.32 |
| MACD | -0.09 | 0.07 |
| Stochastic Oscillator | 10.88 | 4.21 |
Price Performance
Historical ComparisonAbout WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.